|
|
|
Volumn 3, Issue 3, 1996, Pages 202-213
|
|
Novel costimulators in the immune gene therapy of cancer
|
|
Author keywords
Cancer; Costimulation; Gene therapy; Signal transduction
|
|
Indexed keywords
ABATACEPT;
ANTIBODY CONJUGATE;
B7 ANTIGEN;
CD28 ANTIGEN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4;
DIFFERENTIATION ANTIGEN;
LEUKOCYTE ANTIGEN;
LYMPHOCYTE ANTIGEN RECEPTOR;
MEMBRANE ANTIGEN;
TUMOR ANTIGEN;
TUMOR MARKER;
ANIMAL;
BIOLOGICAL MODEL;
CYTOTOXICITY;
GENE THERAPY;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
IMMUNOTHERAPY;
METHODOLOGY;
NATURAL KILLER CELL;
NEOPLASM;
REVIEW;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, CD28;
ANTIGENS, CD80;
ANTIGENS, DIFFERENTIATION;
ANTIGENS, NEOPLASM;
ANTIGENS, SURFACE;
CYTOTOXICITY, IMMUNOLOGIC;
GENE THERAPY;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOCONJUGATES;
IMMUNOTHERAPY;
KILLER CELLS, NATURAL;
MODELS, IMMUNOLOGICAL;
NEOPLASMS;
RECEPTORS, ANTIGEN, T-CELL;
SIGNAL TRANSDUCTION;
T-LYMPHOCYTES;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0030138111
PISSN: 09291903
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (32)
|
|
References (1)
|
